Minerva Neurosciences, Inc. business relationships
Companies named in Minerva Neurosciences, Inc.’s 10-K filed 2026-03-11, and public companies whose annual reports name Minerva Neurosciences, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 4 / 100 Top 3% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in Minerva Neurosciences, Inc.’s annual report 1
“In September 2019 we entered into a long-term commercial supply agreement for roluperidone with Catalent, Inc. ("Catalent"), a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.